#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer stage IV Amyotrophic lateral sclerosis gene carrier Liver abscess Adult T-cell lymphoma/leukaemia refractory Skin cancer Neuroendocrine carcinoma of the skin Hyperchylomicronaemia Acute hepatic failure Congenital disorder of glycosylation Transitional cell cancer of the renal pelvis and ureter Systemic sclerosis pulmonary Stargardt's disease Chondrosarcoma metastatic Endometrial cancer recurrent Infertility female More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Trials in Disease Immunodeficiency congenital Haemophilia B with anti factor IX – Diagnostics Castleman’s disease – Basic Information Angiosarcoma recurrent – Treatment Bronchiolitis obliterans syndrome – Treatment Usher’s syndrome – Trials in Disease Krabbe’s disease – Basic Information Chronic granulomatous disease – Diagnostics Mucopolysaccharidosis I – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexketoprofen Bexotegrast Sxr1096 Img-007 Tenecteplase Codeine Phosphate Hemihydrate Sirolimus Disodium Folinate Kbp-336 Df6002 Ranitidine NERANDOMILAST Aclidinium Bromide Arginine Maralixibat Chloride Etravirine Efzofitimod Estriol Fingolimod Nms-03592088 More therapies…

    Learn about Your Condition

    Testis cancer Abdominal pain Follicular lymphoma stage III Nervous system disorder Ocular melanoma Skin wrinkling Mucosal inflammation Prostate cancer Ehlers-Danlos syndrome Rheumatic disorder Haemorrhage prophylaxis Vascular calcification Conjunctivitis allergic Mantle cell lymphoma Biliary cancer metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diagnosis

  • Evaluation of 18F-DPA-714 PET-MRI imaging for locating epileptic focus in patients with drug-resistant partial epilepsy before surgery

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide
    France

  • Study on the Role of Serotonin and Sodium Chloride in Brain Circuits for Food Avoidance in Patients with Anorexia Nervosa

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Anorexia nervosa
    Investigated Drugs:
    • 3-AMINO-4-[2-[[METHYL((111C)METHYL)AMINO]METHYL]PHENYL]SULFANYLBENZONITRILE
    France

  • Study on the Use of PET Scans with Fludeoxyglucose (18F) for Diagnosing Endometriosis in Patients with Symptoms

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Furosemide
    • Fludeoxyglucose (18F)
    • Iohexol
    France

  • Study of Florastamin (18F) PET/CT Imaging for Detection of Significant Prostate Cancer in Patients with Elevated PSA Levels and Unclear MRI Results

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • (9S,13S)-1-(1-(2-(2-(2-[18F]Fluoroethoxy)Ethoxy)Ethyl)-1H-1,2,3-Triazol-4-Yl)-3,11-Dioxo-2,4,10,12-Tetraazapentadecane-9,13,15-Tricarboxylicacid
    Austria

  • Study on the Effects of Bosentan on Blood Pressure in Patients with Uncontrolled Hypertension

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Bosentan
    France

  • Study on Allergenic Extracts of Mites and Histamine Dihydrochloride for Allergy Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Blomia Tropicalis
    • Dermatophagoides Farinae
    • Dermatophagoides Pteronyssinus
    Spain
Previous Page
1 … 17 18 19 20 21 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!